Labiotech.eu

peter Llewellyn Davies medigene interview

News and Trends 3 Nov 2015

Exclusive from BIO-Europe 2015: Interview of Peter Llewellyn-Davies, CFO at Medigene, Munich-based Immunotherapy Biotech

This is the third interview we publish from BIO (yes, we are working hard). It comes after the interview of Simon Moroney, CEO of MorphoSys and Jane Dancer, CBO of F-star. Medigene is another big/famous Biotech company of Munich, Germany. It was founded over 20 years ago and is now specialised in cell-based therapies. It counts […]

November 3, 2015 - 1 minutemin - By Philip Hemme

News and Trends 3 Nov 2015

€100 Million Investment Round Prepares CureVac For Vaccine Expansion

“The RNA People” at CureVac in Tübingen (Germany) have a new €100M investment into their RNA platform, which has prophylactic purposes for common viruses, pipeline candidates for prostate cancer, lung cancer and research into vaccines for HIV, Tuborculosis and Rabies. Indeed, the financial success surrounding their mRNA work has been startlingly impressive, with the EU […]

November 3, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 3 Nov 2015

Exclusive from BIO-Europe 2015: Interview with F-star, a Cambridge-UK Immuno-oncology Biotech

Second interview of BIO-Europe 2015. This time, it’s a British company from Cambridge (UK): F-star. This morning we spoke with their CBO Jane Dancer. F-star is developing bi-specific antibodies for immuno-oncology and inflammatory disease. It has raised a total of 38 million euros from top EU VCs. Jane Dancer’s business tenure within the field is […]

November 3, 2015 - 1 minutemin - By Philip Hemme

News and Trends 3 Nov 2015

History of Biotech: 25 Years of The Human Genome Project

The birth of the Human Genome Project was now 25 years ago (woah!)…What was the HGP’s significance to biotech? What? The Human Genome Project (HGP) was an international effort with a primary goal; to sequence the entire genetic code of a whole organism (Humans…). It today remains the largest ever world collaborative project, which thrust the […]

November 3, 2015 - 5 minutesmins - By Marie Godar

News and Trends 3 Nov 2015

Potato Plastics! Biodegradable Plastics from Potato Waste

An Italian company specialized in the production of environmentally sustainable materials has created its Minverv PHAs. These are ‘green’ biopolymers with the same thermo-mechanical properties of the substances that make up the traditional plastics, but are instead 100% biodegradable. The goal was to create a plastic that does not pollute the environment and Bio-On, company […]

November 3, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 3 Nov 2015

To IPO or not to IPO when you are a Biotech company? #BIO-Europe 2015

This is the second conference I attended at BIO-Europe. This is an interesting topic when you look at the different EU Biotech companies delaying their IPOs. The conference gathered four big speakers, among them Olivier Litzka, partner from Edmond de Rothschild (part of our TOP 15 EU VCs), Konrad Glund, the CEO of Berlin-based Probiodrug, […]

November 3, 2015 - 4 minutesmins - By Philip Hemme

interview simon moroney labiotech bio europe

News and Trends 2 Nov 2015

Exclusive from BIO-Europe 2015: Interview of Simon Moroney, CEO of leading German Biotech MorphoSys

BIO-Europe is also a great opportunity to meet with top people from EU’s Biotech ecosystem. I had the chance to interview Simon Moroney, the CEO and one of the founders of MorphoSys (part of our top 9 EU-based billion euros Biotechs). The Munich-based company was founded in 1992 and now counts +-350 employees for a market […]

November 2, 2015 - 1 minutemin - By Philip Hemme

News and Trends 2 Nov 2015

How Big can be Small in Biotech – #BIO-Europe 2015 Keynote

As usual at BIO-Europe, the fair starts with an opening keynote, this time with speakers from Merck Healthcare, MedImmune/AstraZeneca and Baxalta. The keynote is basically a discussion between high-level speakers, akin to the talk which took place in Paris during March, when Antoine Papiernik (the prominent European VC from Sofinnova) led a panel discussion with […]

November 2, 2015 - 5 minutesmins - By Philip Hemme

News and Trends 2 Nov 2015

A Glimpse into the DIY Biotech Movement: Biohacking, Vegan Cheese, Algae Beer and Bacterial Art!

Fab Labs have become hugely fashionable since 2010… But what about Bio Fab Labs? Have you ever thought about sharing your RNA or DNA amplification equipment? It can be a massive help for entrepreneurs or students, and Bio Fab Labs are starting to emerge in backyards across the world for Education, Innovation and even creative SynBio art. This new era of DIY […]

November 2, 2015 - 6 minutesmins - By Julie Lellouche

News and Trends 2 Nov 2015

EU’s biggest Biotech Fair, BIO-Europe 2015, is starting … NOW!

The European ecosystem of Biotech will be for the next three days in Munich, Germany. That’s where the BIO-Europe 2015 convention takes place. Yesterday, with Joachim and Will, we drove south from Berlin to Munich to be on-site for the start of the event. This morning, the alarm was set up early and we had to […]

November 2, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 2 Nov 2015

The French Scientist Who Also ‘Discovered’ CRISPR is Finally Recognized with a Prize too

So, we all know the CRISPR Success story with Emmanuelle Charpentier & Jennifer Doudna, who have received multiple awards and constant celebration of their pioneering work in 2012. However, what about the guy who really first described the CRISPR-Cas9 mechanism all the way back in 2007? Finally, he gets some recognition too. Senior DuPont scientist […]

November 2, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 31 Oct 2015

What Happened this Week? An Incredible Woman, CRISPR deal, CAR-T milestone

Monday: Wow, Europe’s leading CRISPR Biotech signs monster €2.29 Billion Deal Tuesday: Meet the French Woman who started a Biotech to Save her Daughter from a Rare Disease Wednesday: Dragen Bio-Processor: UK Partnership to Finally Sequence Domestic Wheat Genome Thursday: Cellectis UCART Milestone: One step closer to a Universal CAR-T Therapy for Blood Cancer Friday: Purple GMO Tomatoes […]

October 31, 2015 - 1 minutemin - By Philip Hemme

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Exclusive from BIO-Europe 2015: Interview of Peter Llewellyn-Davies, CFO at Medigene, Munich-based Immunotherapy Biotech

€100 Million Investment Round Prepares CureVac For Vaccine Expansion

Exclusive from BIO-Europe 2015: Interview with F-star, a Cambridge-UK Immuno-oncology Biotech

History of Biotech: 25 Years of The Human Genome Project

Potato Plastics! Biodegradable Plastics from Potato Waste

To IPO or not to IPO when you are a Biotech company? #BIO-Europe 2015

Exclusive from BIO-Europe 2015: Interview of Simon Moroney, CEO of leading German Biotech MorphoSys

How Big can be Small in Biotech – #BIO-Europe 2015 Keynote

A Glimpse into the DIY Biotech Movement: Biohacking, Vegan Cheese, Algae Beer and Bacterial Art!

EU’s biggest Biotech Fair, BIO-Europe 2015, is starting … NOW!

The French Scientist Who Also ‘Discovered’ CRISPR is Finally Recognized with a Prize too

What Happened this Week? An Incredible Woman, CRISPR deal, CAR-T milestone

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!